Preparation and characterization of vemurafenib microemulsion by Mohammed Jassim Neamah, Entidhar J. Al-Akkam

“… Human melanoma is the most common and malignant type of skin cancer. Vemurafenib has been used for the treatment of malignant or metastatic melanoma. …”
Get full text

Metastatic melanoma and vemurafenib: novel approaches by Ramon Andrade De Mello

Subjects: Get full text

VEMURAFENIB IN TREATMENT OF MELANOMA WITH BRAIN METASTASES by D. R. Naskhletashvili, V. A. Gorbunova, A. Kh. Bekyashev, L. V. Demidov, G. Yu. Kharkevich, S. M. Banov, I. V. Samoylenko, K. А. Baryshnikov, K. V. Orlova, I. А. Utyashev, N. N. Petenko, I. G. Markina, E. A. Moskvina, S. V. Medvedev

“…According to the results of these studies vemurafenib can be recommended as a 1st line targeted drug for treatment of melanoma patients with BRAF V600 mutations and brain metastases. …”
Get full text

Delayed-onset vemurafenib-induced panniculitis by Stephen L. Vance, MD, MBA, Hannah M. Singer, BS, BA, David Silvers, MD, Sameera Husain, MD, Filamer Kabigting, MD

Subjects: Get full text

A Rare Cause of Uveitis: Vemurafenib by Selçuk Sızmaz, Nuhkan Görkemli, Ebru Esen, Nihal Demircan

Subjects: Get full text

The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 Melanoma by Hongmei Cui, Hongmei Cui, Qinghui Wang, Duane D. Miller, Wei Li

Subjects: Get full text

Vemurafenib induces a noncanonical senescence-associated secretory phenotype in melanoma cells which promotes vemurafenib resistance by Jianyu Peng, Zijun Lin, Weichun Chen, Jie Ruan, Fan Deng, Lin Yao, Minla Rao, Xingdong Xiong, Shun Xu, Xiangning Zhang, Xinguang Liu, Xuerong Sun

Subjects: Get full text

Role of vemurafenib in the treatment of disseminated skin melanoma by L V Demidov, I A Utyashev, G Yu Kharkevich

Subjects: Get full text

RASopathic skin eruptions during vemurafenib therapy. by Jeannine D Rinderknecht, Simone M Goldinger, Sima Rozati, Jivko Kamarashev, Katrin Kerl, Lars E French, Reinhard Dummer, Benedetta Belloni

“…Vemurafenib is a potent inhibitor of V600 mutant BRAF with significant impact on progression-free and overall survival in advanced melanoma. …”
Get full text

Vemurafenib and Dabrafenib Downregulates RIPK4 Level by Ewelina Madej, Anna A. Brożyna, Agnieszka Adamczyk, Norbert Wronski, Agnieszka Harazin-Lechowska, Anna Muzyk, Krzysztof Makuch, Michal Markiewicz, Janusz Rys, Agnieszka Wolnicka-Glubisz

Subjects: Get full text

Cutaneous side-effects during therapy of melanoma by vemurafenib by Anna Ankudowicz, Urszula Brzezicka-Ciach, Bożena Wenska

Subjects: “…vemurafenib…”
Get full text

Correction: RASopathic Skin Eruptions during Vemurafenib Therapy. by Jeannine D. Rinderknecht, Simone M. Goldinger, Sima Rozati, Jivko Kamarashev, Katrin Kerl, Lars E. French, Reinhard Dummer, Benedetta Belloni

Get full text

Vemurafenib and cutaneous adverse events - report of five cases by Giselle de Barros Silva, Adriana Pessoa Mendes, Mariana Petaccia de Macedo, Clóvis Antônio Lopes Pinto, Ivana Lameiras Gibbons, João Pedreira Duprat Neto

“…AbstractVemurafenib is a selective inhibitor of V600E-mutant BRAF protein used to treat metastatic and unresectable melanoma. …”
Get full text

Correction: RASopathic Skin Eruptions during Vemurafenib Therapy

Get full text

Can Vemurafenib Induce Vitiligo in Metastatic Melanoma Patients? by Ricardo Ruiz-Villaverde, Daniel Sánchez-Cano

Get full text

Multiple Squamous Cell Carcinoma after Vemurafenib Therapy by Sinem Çiloğlu, Alpay Duran, Şirin Yaşar Pekcan, Aslı Duran

Get full text

Insulin Reduces the Efficacy of Vemurafenib and Trametinib in Melanoma Cells by Osrodek M, Rozanski M, Czyz M

“…Changes induced by vemurafenib and trametinib in glutathione homeostasis and DNA repair gene expression were also attenuated by insulin. …”
Get full text

Structure of the human protein kinase ZAK in complex with vemurafenib. by Mathea, S, Abdul Azeez, K, Salah, E, Tallant, C, Wolfreys, F, Konietzny, R, Fischer, R, Lou, H, Brennan, P, Schnapp, G, Pautsch, A, Kessler, B, Turk, B, Knapp, S

“…Here we report the first crystal structure of ZAK in complex with the B-RAF inhibitor vemurafenib. The co-crystal structure displayed a number of ZAK-specific features including a highly distorted P loop conformation enabling rational inhibitor design. …”

Orbital and chorioretinal manifestations of Erdheim-Chester disease treated with vemurafenib by Laura C. Huang, Katie L. Topping, Dita Gratzinger, Ryanne A. Brown, Beth A. Martin, Ruwan A. Silva, Andrea L. Kossler

“…Keywords: Histiocytosis, Vemurafenib, Orbital, Chorioretinal, Xanthomatous, Lipogranulomatous, BRAF…”
Get full text

A case of bilateral uveitis in a patient treated with vemurafenib by Aysel Mehmet, Athanasia Maria Mikropoulou, Eirini-Kanella Panagiotopoulou, Aristeidis Konstantinidis, Georgios Labiris

Get full text